Frontiers in Neurology · Nov 8, 2026
When the Substrate Changes, the Signal May Follow: Estrogen, Fascia, and Proprioception in Menopause
By Laurice D. Nemetz
Balance decline and fall risk in postmenopausal women are usually attributed to sarcopenia and to aging of the central and vestibular systems. The connective tissue that houses proprioceptors is seldom considered. Fascia is a richly innervated, mechanically responsive continuum. Its fibroblasts express estrogen receptors. In vitro, postmenopausal estradiol concentrations shift fascial fibroblast output toward a collagen-I-dominant matrix, although the direction of change in tissue stiffness in vivo is unresolved with few available studies. Menopause may change the properties of the fascial extracellular matrix, including hydration and mechanical behavior, in ways that may vary by region and potentially alter the mechanical signals reaching embedded mechanoreceptors, thereby contributing to proprioceptive and postural decline. This Perspective reviews anatomical, hormonal, and clinical evidence, including anomalies, and outlines competing explanations, including direct neural effects of estrogen and the contributions of tendon, joint, and cutaneous afferents. It also describes a hypothetical longitudinal study design with explicit control of confounders. Hormone therapy and movement practices are discussed as experimental probes of the mechanism, not as recommendations. The benefits and risks of hormone therapy have a time-dependent component, whereas movement practices improve balance and proprioception with minimal risk. If supported, the hypothesis would identify a peripheral and potentially modifiable contributor to falls in older women. Menopause provides a natural model for investigating how connective tissue influences neural function.